SCHEMBL17287295

SCHEMBL17287295

c1ccc2c(C34CC5CC(CC(C5)C3)C4)n[nH]c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 3/20 0.52
▸ CNR1 P21554 1/20 0.52
▸ KDM4E B2RXH2 4/20 0.44
▸ GAA P10253 2/20 0.44
▸ PDPK1 O15530 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ POLB P06746 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ IDO1 P14902 3/20 0.42
▸ ALPL P05186 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TTK P33981 1/20 0.42
▸ MAPK10 P53779 1/20 0.42
▸ CYP1A2 P05177 1/20 0.39
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ LRRK2 Q5S007 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31747999 0.93 KDM4E (0.47) CNR2CNR1KDM4EGAAPDPK1
SCHEMBL22160417 0.93 KDM4E (0.47) CNR2CNR1KDM4EGAAPDPK1
SCHEMBL1940383 0.78 HSP90AB1 (0.47) CNR2CNR1KDM4EGAAPDPK1
SCHEMBL29184972 0.76 KDM4E (0.45) CNR2CNR1KDM4EGAACYP3A4
SCHEMBL28167618 0.71 ALDH1A1 (0.42) CNR2CNR1KDM4EALDH1A1HPGD
SCHEMBL22160420 0.70 PDPK1 (0.53) PDPK1IDO1LRRK2HTR2AHTR2C
SCHEMBL22160395 0.70 KDM4E (0.42) CNR2CNR1KDM4EGAAPDPK1
SCHEMBL13502779 0.69 CNR2 (1.00) CNR2CNR1KDM4EPOLBCASP7
SCHEMBL5670563 0.69 ALDH1A1 (0.43) KDM4EGAAPOLBALDH1A1HPGD
SCHEMBL10067379 0.67 OPRM1 (0.48) CNR2CNR1KDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023092175-A1 NOVEL P2X7 RECEPTOR ANTAGONISTS THE UNIVERSITY OF SYDNEY (AU) 2023-06-01 — — WO disclosed
US-10591497-B2 Immunoassay for synthetic cannabinoids of the adamantyl indazole/indole-3-carboxamide family RANDOX LABORATORIES LTD. (GB) 2020-03-17 — — US disclosed
US-10591497-B2 Immunoassay for synthetic cannabinoids of the adamantyl indazole/indole-3-carboxamide family RANDOX LABORATORIES LTD. (GB) 2020-03-17 — — US disclosed
EP-2950103-B1 IMMUNOASSAY FOR SYNTHETIC CANNABINOIDS OF THE 3-ADAMANTANYL INDAZOLE/INDOLE-3-CARBOXAMIDE FAMILY RANDOX LABORATORIES LTD (GB) 2018-10-17 — — EP disclosed
US-20150346227-A1 IMMUNOASSAY FOR SYNTHETIC CANNABINOIDS OF THE ADAMANTYL INDAZOLE/INDOLE-3-CARBOXAMIDE FAMILY NORTHERN BANK LIMITED (IE) 2015-12-03 — — US disclosed
US-20150346227-A1 IMMUNOASSAY FOR SYNTHETIC CANNABINOIDS OF THE ADAMANTYL INDAZOLE/INDOLE-3-CARBOXAMIDE FAMILY NORTHERN BANK LIMITED (IE) 2015-12-03 — — US disclosed
EP-2950103-A1 IMMUNOASSAY FOR SYNTHETIC CANNABINOIDS OF THE 3-ADAMANTANYL INDAZOLE/INDOLE-3-CARBOXAMIDE FAMILY Randox Laboratories Ltd. (GB) 2015-12-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150346227-A1 IMMUNOASSAY FOR SYNTHETIC CANNABINOIDS OF THE ADAMANTYL INDAZOLE/INDOLE-3-CARBOXAMIDE FAMILY CNR2, CNR1, IDO1 CNR2 1/4885CNR1 2/4885KDM4E 2943/4885
US-10591497-B2 Immunoassay for synthetic cannabinoids of the adamantyl indazole/indole-3-carboxamide family CNR2, CNR1, IDO1 CNR2 1/4885CNR1 2/4885KDM4E 2943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback